News

Read our latest news.

  • October 4, 2022

BostonGene Announces Publication in Cell Reports Revealing Spatial Heterogeneity in the Tumor Microenvironment of Multiregional Clear Cell Renal Cell Carcinoma Biopsies

More
  • September 21, 2022

BostonGene Showcases Lifesaving Cancer Diagnostic and Treatment Recommendation Test at The 81st Annual Meeting of the Japanese Cancer Association

More
  • September 7, 2022

BostonGene Announces Strategic Alliance with the Massachusetts General Hospital Cancer Center

More
  • August 9, 2022

BostonGene Announces Publication in Cancer Cell Revealing the Development of a Machine Learning Cellular Deconvolution Algorithm that Accurately Reconstructs the Tumor Microenvironment and Supports Oncology Clinical Decision-making

More
  • July 12, 2022

BostonGene Announces New Master Agreement with Leading Cancer Center in New York City

More
  • June 3, 2022

BostonGene to Present at the 2022 American Society of Clinical Oncology Annual Meeting

More
  • May 10, 2022

BostonGene Announces Integration With NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)

More
  • April 7, 2022

BostonGene Announces Acceptance of Six Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2022

More
  • April 6, 2022

BostonGene Announces $150 Million Series B Funding at a Multi-Billion Dollar Valuation, Propelling the Company to Unicorn Status

More